Weihao Zhang
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Clinical outcomes and prognostic factors of systemic therapy combined with interventional treatment in hepatocellular carcinoma: a multicenter retrospective case series.
Journal: Translational cancer research
Published: September 02, 2025
Hepatic arterial infusion chemotherapy combined with lenvatinib and programmed death receptor-1 inhibitors for hepatocellular carcinoma with Vp4 portal vein tumor thrombus: a multicenter, propensity score matching comparative study.
Journal: Hepatology international
Published: April 27, 2025
The role of APOBEC mutagenesis in the progression and therapeutic guidance of pancreatic cancer.
Journal: Genomics
Published: March 25, 2025
Conversion study of hepatocellular carcinoma using HAIC combined with lenvatinib and PD-1/L1 immunotherapy under the guidance of BCLC staging.
Journal: Frontiers in immunology
Published: March 20, 2025
The aminophospholipid transporter, ATP8B3, as a potential biomarker and target for enhancing the therapeutic effect of PD-L1 blockade in colon adenocarcinoma.
Journal: Genomics
Published: April 10, 2024
Efficacy and Safety of CT-guided Percutaneous Cryoablation for Hepatocellular Carcinoma at High-risk Sites.
Journal: Academic radiology
Published: January 09, 2024
Sintilimab, bevacizumab biosimilar, and HAIC for unresectable hepatocellular carcinoma conversion therapy: a prospective, single-arm phase II trial.
Journal: Neoplasma
Published: August 06, 2023
The in vivo and in vitro corrosion behavior of MgO/Mg-Zn-Ca composite with different Zn/Ca ratio.
Journal: Frontiers in bioengineering and biotechnology
Published: May 15, 2023
ABHD17C, a metabolic and immune-related gene signature, predicts prognosis and anti-PD1 therapy response in pancreatic cancer.
Journal: Discover oncology
Published: March 11, 2023
Retraction notice to "MicroRNA-498 disturbs the occurrence and aggression of colon cancer through targeting MDM2 to mediate PPARγ ubiquitination" [Life Sci. 277 (2021) 119225].
Journal: Life sciences
Published: February 22, 2023
Hepatic arterial infusion chemotherapy combined with anti-PD-1/PD-L1 immunotherapy and molecularly targeted agents for advanced hepatocellular carcinoma: a real world study.
Journal: Frontiers in immunology
Published: December 19, 2022
Hepatic arterial infusion chemotherapy in hepatocellular carcinoma: A bibliometric and knowledge-map analysis.
Journal: Frontiers in oncology
Published: October 17, 2022
Last Updated: 09/26/2026